COVID-19: Could Lateral Flow Test Using Glycan Recognition Be A Rapid Testing Breakthrough?
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
You may also be interested in...
The deal combines two of the largest providers of sterilization and infection-prevention products to create a $4bn-plus-revenue business.
One of the few silver linings in a tumultuous year dominated by a global pandemic was the huge boost given to the diagnostics and telehealth sectors. But while new technologies for rapid testing for COVID-19 and remote monitoring tools dominated the headlines, there were also key developments in robotic surgery, early-stage cancer testing and cardiac arrhythmia treatment. Here are Medtech Insight’s most popular R&D stories in 2020.
After years of setbacks, the company will launch its device in Europe as a bridge to transplant in heart failure patents.